Bioventus (BVS) Long-Term Deferred Tax (2021 - 2026)

Bioventus (BVS) has 4 years of Long-Term Deferred Tax data on file, last reported at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 16.38% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 16.38% YoY), and the FY2025 full-year result was $5.5 million, up 16.38% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $5.5 million, roughly flat from $5.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $7.4 million in Q3 2024 and bottomed at $4.7 million in Q4 2024.
• The 3-year median for Long-Term Deferred Tax is $5.1 million (2024), against an average of $5.5 million.
• Peak annual rise in Long-Term Deferred Tax reached 16.38% in 2025, while the deepest fall reached 35.84% in 2025.
• A 3-year view of Long-Term Deferred Tax shows it stood at $4.7 million in 2024, then climbed by 16.38% to $5.5 million in 2025, then changed by 0.0% to $5.5 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $5.5 million (Q1 2026), $5.5 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison